UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) JULY 24, 1995
PHARMAKINETICS LABORATORIES, INC.
(Exact Name of Registrant as Specified in its Charter)
MARYLAND
(State or Other Jurisdiction of Incorporation)
0-11580 52-1067519
(Commission File Number) (I.R.S. Employer Identification Number)
302 WEST FAYETTE STREET, BALTIMORE, MARYLAND 21201
(Address of Principal Executive Offices) (Zip Code)
(410) 385-4500
(Registrant's Telephone Number, Including Area Code)
</page>
<PAGE> 1
Item 6. Resignation of Registrant's Director
On July 24, 1995, V. Brewster Jones resigned his positions as
President, Chief Executive Officer and Director of PharmaKinetics
Laboratories, Inc. Mr. Jones resigned to pursue personal
interests. He will remain with the Company as a consultant.
The Board of Directors appointed James K. Leslie, previously
Executive Vice President and Chief Operating Officer, to the
positions of President and Chief Executive Officer, and elected him
to serve as a Director of the Company effective July 24, 1995.
</page>
<PAGE> 2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
PHARMAKINETICS LABORATORIES, INC.
(Registrant)
July 27, 1995 /s/Taryn L. Kunkel
(Date) Taryn L. Kunkel
Vice President and
Chief Financial Officer
